Member Info for neilrich3

Would appear that Simon Cook and James Newton have both departed Novacyt this past week, both had been employed within sales orientated roles.

Lovely Jubbly.....who said that this was purely a COVID play.

BabyHuey, I must be making it up then, do you really think I'd go to the effort of posting something that wasn't true. The text message received from Barclays at 1630 Friday advising that my order had 'been completed' must be wrong too.

BabyHuey, Have no idea how it would appear, however the 7700 SELL was the last trade before the close, although it was my BUY going through. The limit order that I had placed was for 165p, however executed at <164p (Barclays).

I purchased an additional 7700 on Friday, limit order that I placed on the morning which executed at 1629, was listed as a SELL, however it was a BUY.

Is it not the case that the R&D team is very well paid? Would like to think that Paul and the team are paid above market rate, therefore negating the need for a large incentive scheme, but who knows.

I'm think that Blackbird is still invested, he posts upon this board under a different name and has been posting Today. Also, Blackbird posted upon Twitter last week re. NCYT.

Hillseeker,
James McCarthy purchased 10,000 shares at approximately £9.00, therefore not true to say no shares.

DRB83, Totally agree, however the UK is our largest single marker and I'd imagine the biggest market for ProMate, therefore the most important market for Co-Prep. They cannot launch Co-Prep until Pro-Mate's future is assured via CTDA approval.

If Mandy has confirmed that Co-Prep is to be launched this Month, then one has to assume that they are very confident that Pro-Mate shall receive full CTDA before the end of the Month.

Once the dispute is finally resolved, don't expect any specific detail or explanation as to the true nature of the issue.

My biggest concern at present is the CTDA validations, why is it taking so long? Also, I firmly believe that this is the reason as to why Co-Prep has not been launched, the company perhaps taking the view that whilst Pro-Mate is listed upon the Temporary Protocol, there was a risk launching Co-Prep, which is designed to work with Pro-Mate, the risk being that come the end of Feb Pro-Mate has to be withdrawn from sale within the UK, therefore no product to work with Co-Prep. I'd imagine that the UK is likely to be the initial market for Co-Prep.

"It is has acquired and instrument arm to add to its testing capability"

Worth pointing out that the cash paid to acquire IT-IS International is equal to Today's Enterprise value for Novacyt of £10m. The market could not value a **** up in a brewery!

Work that one out, because I'm struggling!!

Hardly the best time to relax restrictions.
https://twitter.com/drajm/status/1488155705291214850
If omicron was mild it would not be causing Paediatric hospital admissions in Europe & England THREE times higher than seen during the Jan 2021 winter peak.

tkr234 You're talking BS. What change of the BoD? The only change upon the BoD is the new CEO. Graham is not pulling the strings.

To be fair to my earlier post, Pro-mate is upon the temporary protocol which is valid until 28 February 2022. The UK remains an important market.

No idea as to the specific reason, it was just a thought, lets the hope that the launch is announced along with a massive order for the device, you never know.

No idea as to the reason for the delay, although have they purposely delay launch pending successful CTDA approval for the outstanding COVID tests?

Over the weekend I speculated that Co-prep had possibly been cancelled as part of David Allmond's review, having been in contact with the company, Novacyt have confirmed that this is not the case and that 'Co-prep is still to be launched.'

Mortality rates are rising too....yet Omicron is milder apparently.

DRB83, There's actually 24 vacancies listed upon the Novacyt website.